Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.24.1.u1
Stockholders' Equity (Details) - USD ($)
$ in Thousands, shares in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation expense $ 7,600 $ 5,600  
Accrued expenses and other current liabilities $ 161,550   $ 185,305
Equity Plan 2021      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Accrued expenses and other current liabilities     $ 18,100
Restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 1.6    
Restricted Stock Units Time Vested      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 1.1    
Restricted Stock Units Time Vested | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 3 years    
Restricted Stock Units Time Vested | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 4 years    
Restricted Stock Units Performance Vesting      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 0.5    
Performance Stock Units (PSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 0.5    
Vesting period 3 years    
Percentage of shares to vest 33.00%    
Performance Shares, Leverage Ratio      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 0.2    
Performance Shares, Adjusted EBITDA      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 0.3